We’ll Ensure You Always Get The Best Result.

Partnering for Progress: Why Provigilance is a Vital Part of Your Cancer Trial

1. Expertise in Oncology: SMOs with experience in oncology bring valuable knowledge and expertise to cancer trials, ensuring that studies are designed and conducted with the latest scientific understanding and regulatory requirements.
2. Access to Patient Populations: SMOs often have established relationships with cancer treatment centers, hospitals, and patient advocacy groups, facilitating access to diverse patient populations and improving recruitment rates.
3. Regulatory Compliance: Cancer trials involve complex regulatory requirements, and SMOs ensure that studies are conducted in compliance with local and international regulations, reducing the risk of delays or non-compliance.
4. Data Quality and Integrity: SMOs implement robust data management systems to ensure data quality and integrity, which is critical in cancer trials where small sample sizes and complex endpoints require precise data collection and analysis.
5. Site Selection and Management: SMOs identify and manage sites with the right investigators, patient pools, and infrastructure, ensuring that studies are conducted efficiently and effectively.

Streamline Your Clinical Trials: Unlock the Benefits of Partnering with an SMO”

1. Improved Recruitment Rates: PCR leverage their networks and expertise to recruit patients more efficiently, reducing study timelines and costs.
2. Enhanced Data Quality: PCR ensure that data is collected, managed, and analyzed according to GCP standards, reducing errors and improving data integrity.
3. Reduced Regulatory Risk: PCR team are well-versed in regulatory requirements, reducing the risk of non-compliance and ensuring that studies are conducted in accordance with local and international regulations.
4. Increased Efficiency: PCR handle site management, data management, and regulatory compliance, allowing sponsors and CROs to focus on other aspects of the study.
5. Access to Specialized Expertise: PCR bring specialized expertise in oncology and cancer trials, providing valuable insights and guidance throughout the study.

– 30% improvement in recruitment rates

– 25% reduction in study timelines

– 20% reduction in costs